Refine your results

to


Search

Unrestricted access to HCV therapy cost-effective for Medicaid beneficiaries

Show Citation

July 11, 2016

AUTHORS:

Chidi A, Bryce CL, Donohue JM, Fine MJ, Landsittel DP, Myaskovsky L, Rogal SS, Switzer GE, Tsung A, Smith KJ.

BACKGROUND:

Interferon-free hepatitis C treatment regimens are effective but very costly. The cost-effectiveness, budget, and public health impacts of current Medicaid treatment policies restricting treatment to patients with advanced disease remain unknown. ...

Advertisement
Advertisement